fingolimod hydrochloride has been researched along with rotenone in 1 studies
Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (rotenone) | Trials (rotenone) | Recent Studies (post-2010) (rotenone) |
---|---|---|---|---|---|
2,771 | 157 | 2,062 | 4,407 | 6 | 1,648 |
Protein | Taxonomy | fingolimod hydrochloride (IC50) | rotenone (IC50) |
---|---|---|---|
Bile salt export pump | Homo sapiens (human) | 8 | |
NADH-ubiquinone oxidoreductase chain 1 | Bos taurus (cattle) | 0.015 | |
NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial | Bos taurus (cattle) | 0.0051 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 3.6486 | |
5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 0.87 | |
Acyl carrier protein, mitochondrial | Bos taurus (cattle) | 0.0051 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, M; Liu, Q; Wood, K; Yang, L; Yang, X; Zhao, P; Zhu, X | 1 |
1 other study(ies) available for fingolimod hydrochloride and rotenone
Article | Year |
---|---|
Neuroprotective effects of fingolimod in mouse models of Parkinson's disease.
Topics: Animals; Cell Line, Tumor; Fingolimod Hydrochloride; Gene Expression Regulation; Humans; Male; Mice; Neuroblastoma; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Receptors, Lysosphingolipid; Rotenone; Sphingosine-1-Phosphate Receptors | 2017 |